Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16811
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKhor, Yet H-
dc.contributor.authorGoh, Nicole SL-
dc.contributor.authorMcDonald, Christine F-
dc.contributor.authorHolland, Anne E-
dc.date2017-08-10-
dc.date.accessioned2017-08-18T00:43:02Z-
dc.date.available2017-08-18T00:43:02Z-
dc.date.issued2017-12-
dc.identifier.citationAnnals of the American Thoracic Society 2017; 14(12): 1772-1778en_US
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/16811-
dc.description.abstractRATIONALE: Domiciliary oxygen therapy (DOT) is commonly prescribed for patients with interstitial lung disease (ILD) and hypoxaemia, although evidence supporting benefit is limited. OBJECTIVES: The aim of this study was to explore perspectives of respiratory physicians about DOT in patients with ILD. METHODS: A qualitative study was undertaken with 26 respiratory physicians from Australia. Interviews were transcribed verbatim and coded independently by two investigators. Themes were established by consensus. RESULTS: Physicians reported symptomatic relief as the main indication for prescribing DOT in ILD. Concerns were raised regarding the applicability of current clinical guidelines for DOT to ILD. Compared to patients with other lung diseases, there was a lower threshold for DOT prescription for patients with ILD. Physicians perceived patients with ILD complied better with recommended DOT prescription. There was significant variation in infrastructure for oxygen assessment and prescription, patient support and equipment provision amongst institutions and states. Various patients' attitudes and experiences towards DOT were reported, but notable was physicians' perception of significant anxiety in most patients using DOT due to social stigma and concerns that DOT signified end-stage disease. CONCLUSIONS: Oxygen therapy was primarily prescribed for symptomatic management in patients with ILD. Education provision and supports regarding DOT varied significantly.en_US
dc.titleOxygen therapy for interstitial lung disease: physicians' perceptions and experiencesen_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleAnnals of the American Thoracic Societyen_US
dc.identifier.affiliationDepartment of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationInstitute for Breathing and Sleep, Heidelberg, Victoria, Australiaen_US
dc.identifier.affiliationUniversity of Melbourne, School of Medicine, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationAlfred Health, Department of Allergy, Immunology and Respiratory Medicine, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationLa Trobe University, Physiotherapy, Melbourne, Victoria, Australiaen_US
dc.identifier.affiliationAlfred Health, Physiotherapy, Melbourne, Victoria, Australiaen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/28796538en_US
dc.identifier.doi10.1513/AnnalsATS.201705-372OCen_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-6481-3391en
dc.identifier.orcid0000-0003-2061-845Xen
dc.identifier.orcid0000-0002-5434-9342en
dc.identifier.orcid0000-0003-2065-4346en
dc.type.austinJournal Articleen_US
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.grantfulltextnone-
item.openairetypeJournal Article-
crisitem.author.deptRespiratory and Sleep Medicine-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptMedicine (University of Melbourne)-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptRespiratory and Sleep Medicine-
crisitem.author.deptInstitute for Breathing and Sleep-
crisitem.author.deptPhysiotherapy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

6
checked on Feb 5, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.